TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas

  1. Melo, M.
  2. Da Rocha, A.G.
  3. Vinagre, J.
  4. Batista, R.
  5. Peixoto, J.
  6. Tavares, C.
  7. Celestino, R.
  8. Almeida, A.
  9. Salgado, C.
  10. Eloy, C.
  11. Castro, P.
  12. Prazeres, H.
  13. Lima, J.
  14. Amaro, T.
  15. Lobo, C.
  16. Martins, M.J.
  17. Moura, M.
  18. Cavaco, B.
  19. Leite, V.
  20. Cameselle-Teijeiro, J.M.
  21. Carrilho, F.
  22. Carvalheiro, M.
  23. Máximo, V.
  24. Sobrinho-Simões, M.
  25. Soares, P.
Journal:
Journal of Clinical Endocrinology and Metabolism

ISSN: 1945-7197,  0021-972X

Year of publication: 2014

Volume: 99

Issue: 5

Type: Article

DOI: 10.1210/JC.2013-3734 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus